CAS No. : 106730-54-5

Product Details
For research use only. Not Intended for Therapeutic Use!
Cat No:I000326
Molecular Formula:C14H10N4O
Molecular Weight:250.26
Price:Get quote
We match the lowest price on market.

Your information is safe with us.

Cat No:I000326
Cas No:106730-54-5

Olprinone(Loprinone) is a selective phosphodiesterase 3 (PDE3) inhibitor.
IC50 value:
Target: PDE3
Olprinone is used as cardiotonic agent with positive inotropic and vasodilating effects. Olprinone has been reported to improve microcirculation and attenuate inflammation. Olprinone is often used to increase cardiac output after cardiopulmonary bypass (CPB). Olprinone was infused at a rate of 0.2 μg/kg/min when weaning from CPB was started. Olprinone has also shown potent antioxidative and anti-inflammatory effects in the meconium-induced oxidative lung injury.

[1]. Tsubokawa T, Ishizuka S, Fukumoto K, et al. The effect of hemodilution by cardiopulmonary bypass on protein binding of olprinone. J Anesth. 2012 .
[2]. Mokra D, Drgova A, Pullmann R Sr, et al. Selective phosphodiesterase 3 inhibitor olprinone attenuates meconium-induced oxidative lung injury. Pulm Pharmacol Ther. 2012 Jun;25(3):216-22.
[3]. Yamanaka H, Hayashi Y, Kamibayashi T, Mashimo T. Effect of olprinone, a phosphodiesterase III inhibitor, on balance of cerebral oxygen supply and demand during cardiopulmonary bypass. J Cardiovasc Pharmacol. 2011 May;57(5):579-83.
[4]. Mazzon E, Esposito E, Di Paola R, et al. Olprinone, a specific phosphodiesterase (PDE)-III inhibitor, reduces the development of multiple organ dysfunction syndrome in mice. Pharmacol Res. 2011 Jul;64(1):68-79.

Related Products
  • CAS No. :78415-72-2
    Product Name:


    Cat No: A000290 View details
  • CAS No. :224785-90-4
    Product Name:


    Cat No: I002729 View details
  • CAS No. :959705-64-7
    Product Name:

    TC-E 5005

    Cat No: I010981 View details
  • CAS No. :505068-32-6
    Product Name:


    Cat No: I011273 View details